Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - live attenuated oka/merck strain of varicella-zoster virus - injection, powder, lyophilized, for suspension - 19,400 pfu/dose

Canada - English - Health Canada

merck canada inc - pneumococcal vaccine polyvalent - solution - 25mcg - pneumococcal vaccine polyvalent 25mcg - vaccines

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - varicella virus (oka strain) live attenuated - pdr+solv for susp for inj - > 1350 pfu - varicella zoster vaccines

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bio products laboratory ltd - varicella-zoster immunoglobulin human - solution for injection - 250mg

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - human immunoglobulin g, quantity: 160 mg/ml; zoster immunoglobulin, quantity: 200 iu - injection, solution - excipient ingredients: water for injections; glycine; human immunoglobulin a - indications as at 8 august 2002 : zoster immunoglobulin is indicated for prophylaxis against varicella in patients who meet all four of the criteria listed below: 1. one of the following underlying illnesses or conditions: a. neoplastic disease (leukaemia or lymphoma); b. congenital or acquired immunodeficiency; c. immunosuppressive therapy with steroids or antimetabolites. 2. one of the following types of exposure to chickenpox or shingles patients: a. household contact; b. playmate contact (>1 hour play indoors); c. hospital contact (in same 2 to 4 bedroom or adjacent beds in a large ward); d. newborn contact (newborn of mother who had onset of chickenpox <5 days before delivery or within 48 hours after delivery); e. premature infant (>= 28 weeks gestation) whose mother lacks a prior history of chickenpox; f. premature infant (< 28 weeks gestation or <= 1000g) regardless of maternal history. 3. negative or unknown history of chickenpox. 4. if zoster immunoglobulin can be administered within 96 hours after exposure. zoster immunoglobulin, normal immunoglobulin (immunoglobulin for intramuscular use) or plasma are of no value in the treatment of established varicella or zoster infection. high levels of circulating antibody do not prevent dissemination of infection. zoster immunoglobulin is not indicated for prophylactic use in immunodeficient children or adults when there is a history of varicella, unless the patient's immunosuppressed status is that which is associated with bone marrow transplantation.

Canada - English - Health Canada

glaxosmithkline inc - mumps virus vaccine live attenuated (jeryl lynn strain); measles virus vaccine live attenuated; rubella virus vaccine live attenuated (wistar ra27/3 strain); varicella-zoster virus vaccine live attenuated (oka-strain) - powder for solution - 25118.9ccid50; 1000ccid50; 1000ccid50; 1995.2623ccid50 - mumps virus vaccine live attenuated (jeryl lynn strain) 25118.9ccid50; measles virus vaccine live attenuated 1000ccid50; rubella virus vaccine live attenuated (wistar ra27/3 strain) 1000ccid50; varicella-zoster virus vaccine live attenuated (oka-strain) 1995.2623ccid50 - vaccines

Canada - English - Health Canada

glaxosmithkline inc - mumps virus vaccine live attenuated (jeryl lynn strain); measles virus vaccine live attenuated; rubella virus vaccine live attenuated (wistar ra27/3 strain); water - kit - 10000ccid50; 1000ccid50; 1000ccid50; 0.5ml - mumps virus vaccine live attenuated (jeryl lynn strain) 10000ccid50; measles virus vaccine live attenuated 1000ccid50; rubella virus vaccine live attenuated (wistar ra27/3 strain) 1000ccid50; water 0.5ml - vaccines

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pharmaniaga lifescience sdn. bhd. - live, attenuated varicella zoster virus (oka/sk strain) -

Canada - English - Health Canada

glaxosmithkline inc - varicella-zoster virus glycoprotein e antigen - suspension - 50mcg - varicella-zoster virus glycoprotein e antigen 50mcg - vaccines

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - varicella vaccine - live -